Thrive Earlier Detection

Cambridge, United States

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

Jan 2023

Venture - Series Unknown

Biotechnology Health Care Health Diagnostics Medical

Top Investors

Lux CapitalSands Capital VenturesJanus Henderson InvestorsCatalio Capital ManagementPerceptive Advisors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Thrive Earlier Detection

Who are Thrive Earlier Detection's investors?

Thrive Earlier Detection's investors include Lux Capital, Sands Capital Ventures, Janus Henderson Investors, Catalio Capital Management, Perceptive Advisors.

Where is Thrive Earlier Detection headquartered?

Thrive Earlier Detection is headquartered in Cambridge, United States.

What does Thrive Earlier Detection do?

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

What stage is Thrive Earlier Detection at?

Thrive Earlier Detection is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2023.

MLA

"Thrive Earlier Detection — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/thrive-earlier-detection. Accessed July 1, 2026.

APA

VCBacked. (2023). Thrive Earlier Detection — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/thrive-earlier-detection

Wikipedia (cite web)

{{cite web |title=Thrive Earlier Detection — Funding & Investors |url=https://www.vcbacked.co/company/thrive-earlier-detection |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2023.